Skip to content

A clinical trial to study the effectiveness of vidanga nagaradi churna in borderline high dyslipidemia

Effectiveness of vidanga nagaradi churna in borderline high dyslipidemia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072840
Enrollment
30
Registered
2024-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E789- Disorder of lipoprotein metabolism, unspecified

Interventions

None listed

Sponsors

Dr Cashmi Jeswind
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Participants of age group 30-60 2)On NCEP ATP 3 Guidelines basis having serum total cholesterol level-200-239mg/dl, LDL-130-159mg/dl, Triglycerides-150-199mg/dl

Exclusion criteria

Exclusion criteria: Diagnosed Case of CAD under medication. Diagnosed Case of Renal disorders under medication. Diagnosed Case of Dyslipidemia under medication.

Design outcomes

Primary

MeasureTime frame
Reduction in Serum Total Cholesterol levelTimepoint: On 0th day and 61st day

Secondary

MeasureTime frame
Reduction in serum LDL and Triglycerides level.Timepoint: 0th day and 61st day

Countries

India

Contacts

Public ContactDr Asha Karunakaran K

Governement Ayurveda College, Trivandrum

cashmijeswindupsc@gmail.com9496695431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026